CCO Independent Conference Highlights of the IASLC 2022 World Conference on Lung Cancer*

August 6-9, 2022; Vienna, Austria

Download capsule summaries highlighting key studies from IASLC 2022 WCLC and then read expert insights on these studies in our Expert Analysis text module.

Wade T. Iams, MD, MSCI

Heather Wakelee, MD

WCLC Highlights

Slideset

2 Capsule Summary Slidesets

View Slidesets

CodeBreaK101: Phase Ib/II Study With Sotorasib + RMC-4630, an SHP2 Inhibitor, in Advanced NSCLC and Other Solid Tumors With KRAS p.G12C Mutation

DeLLphi-300: Updated Data From Phase I Study of Tarlatamab, a DLL3-Targeted T-Cell Engager, in Relapsed/Refractory SCLC

ClinicalThought

An Expert’s Guide to WCLC 2022: A Preview of the Top Abstracts

View ClinicalThought

Read about key studies highlighted by experts being presented at the upcoming IASLC 2022 WCLC annual meeting. The CCO WCLC Conference Coverage program will have the information you need to understand and integrate the latest oncology data into your clinical practice.

Wade T. Iams, MD, MSCI

Heather Wakelee, MD Released: August 5, 2022